Cough, cold and allergy (hay fever) remedies in Belgium is seeing a marked contraction in 2026, expected to decline by 7% in current terms to EUR290 million, while Western Europe overall is set to record steady expansion, highlighting the relative underperformance in Belgium. This lack of dynamism is primarily driven by a combination of milder weather, fewer respiratory illnesses, and an accelerating shift in consumer spending from symptom-based treatments to prevention-oriented products such as vitamins, minerals, and immune support solutions. The landscape remains highly competitive yet fragmented, with no single company commanding more than an 11% share, and performances are increasingly shaped by the ability to offer trusted brands, scientific validation, and pharmacist endorsement — attributes that continue to differentiate leading products such as Nesivine, Rhinospray, and Allegra. The most resilient growth is seen by systemic antihistamines/allergy remedies, supported by environmental changes leading to longer pollen seasons and by innovations like real-time pollen alerts that prompt earlier intervention. For sustained success, brands must leverage scientific credibility, pharmacist partnerships, and a strategic focus on prevention and wellness, while also adapting to the rapid evolution of retail channels and consumer demand for convenience, value, and natural health options.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Belgium with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Belgium, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Cough, Cold and Allergy (Hay Fever) Remedies in Belgium report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Belgium?
- Which are the leading brands in Cough, Cold and Allergy (Hay Fever) Remedies in Belgium?
- How are products distributed in Cough, Cold and Allergy (Hay Fever) Remedies in Belgium?
- How has the regulatory and operating environment for Cough, Cold and Allergy (Hay Fever) Remedies changed in Belgium?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Cough, Cold and Allergy (Hay Fever) Remedies
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Key Industry Trends
Consumer spending moves from symptom relief to prevention
AirAllergy alerts drive earlier allergy treatment as pollen seasons intensify
Pharmacist trust keeps brands like Nesivine and Rhinospray ahead of generics
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Allergy remedies to anchor steady growth as structural drivers intensify
Move to prevention and channel diversification set to reshape competitive strategies
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Opella Healthcare leverages portfolio breadth to defend leadership
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies retain trust, while Medi-Market stands out
Retail e-commerce gains traction with convenience and wide product assortment
Chart 1 Retail Channels 2021-2026
Preventive wellness redefines product development priorities
Digital pollen tracking transforms allergy product innovation
Scientific credibility sustains brand advantage in a shifting market
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Cough, Cold and Allergy (Hay Fever) Remedies
- Antihistamines/Allergy Remedies (Systemic)
-
- Paediatric Allergy Remedies
- Paediatric Cough/Cold Remedies
- Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
- Cough Remedies
-
- Nasal Sprays
- Oral Decongestants
- Inhalant Decongestants
- Decongestant Rubs
- Nasal Decongestant Drops
- Nasal Decongestant Plasters
- Medicated Confectionery
- Pharyngeal Preparations
Cough, Cold and Allergy (Hay Fever) Remedies
This is the aggregation of decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, antihistamines and paediatric cough, cold and allergy remedies.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!